Merck is hell-bent on becoming a major player in the lucrative immune-oncology space as its blockbuster cancer drug Keytruda met its goal of extending the lifespan of cancer patients. https://news.alphastreet.com/merck-sets-the-bar-high-for-rivals-with-positive-keytruda-trial-results/
That's great so now maybe we can get rid of our PC onc pods? What an embarrassment. Time to grow up and act like real competitors.
